{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T05:57:56Z","timestamp":1723096676884},"reference-count":10,"publisher":"Sociedade Portuguesa de Reumatologia","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ARP Rheumatol"],"DOI":"10.63032\/duxg5519","type":"journal-article","created":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T18:52:06Z","timestamp":1715194326000},"page":"70-72","source":"Crossref","is-referenced-by-count":0,"title":["Managing IgG4-related disease \u2013 the Portuguese rheumatology cohort"],"prefix":"10.63032","volume":"3","author":[{"name":"Rheumatology, Unidade Local de Sa\u00fade do Alto Minho","sequence":"first","affiliation":[]},{"given":"Hugo","family":"Parente","sequence":"first","affiliation":[]},{"given":"Adriana","family":"Carones","sequence":"additional","affiliation":[]},{"name":"Rheumatology, Centro Hospitalar e Universit\u00e1rio de Coimbra","sequence":"additional","affiliation":[]},{"given":"Augusto","family":"Silva","sequence":"additional","affiliation":[]},{"name":"Rheumatology, Centro Hospitalar universit\u00e1rio Lisboa Norte","sequence":"additional","affiliation":[]},{"given":"Bruna","family":"Silva","sequence":"additional","affiliation":[]},{"name":"Rheumatology, Centro Hospitalar Universit\u00e1rio do S\u00e3o Jo\u00e3o","sequence":"additional","affiliation":[]},{"given":"Carlos","family":"Costa","sequence":"additional","affiliation":[]},{"name":"Rheumatology, Centro Hospitalar de Tr\u00e1s-Os-Montes e Alto Douro","sequence":"additional","affiliation":[]},{"given":"Catarina","family":"Dantas Soares","sequence":"additional","affiliation":[]},{"name":"Rheumatology, Unidade Local de Sa\u00fade do Alto Minho","sequence":"additional","affiliation":[]},{"given":"In\u00eas","family":"Santos","sequence":"additional","affiliation":[]},{"name":"Rheumatology, Centro Hospitalar Tondela - Viseu","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 Miguel","family":"Bernardes","sequence":"additional","affiliation":[]},{"name":"Rheumatology, Centro Hospitalar Universit\u00e1rio do S\u00e3o Jo\u00e3o","sequence":"additional","affiliation":[]},{"given":"Manuel","family":"Silv\u00e9rio-Ant\u00f3nio","sequence":"additional","affiliation":[]},{"name":"Rheumatology, Centro Hospitalar universit\u00e1rio Lisboa Norte","sequence":"additional","affiliation":[]},{"given":"Rita","family":"Pinheiro Torres","sequence":"additional","affiliation":[]},{"name":"Rheumatology, Centro Hospitalar de Lisboa Ocidental","sequence":"additional","affiliation":[]},{"given":"Filipa","family":"Teixeira","sequence":"additional","affiliation":[]},{"name":"Rheumatology, Unidade Local de Sa\u00fade do Alto Minho","sequence":"additional","affiliation":[]}],"member":"49459","published-online":{"date-parts":[[2024,3]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1155\/2012\/358371","article-title":"Prevalence of IgG4-Related Disease in Japan Based on Nationwide Survey in 2009","volume":"2012","author":"Uchida","year":"2012","unstructured":"1. Uchida K, Masamune A, Shimosegawa T, Okazaki K. Prevalence of IgG4-Related Disease in Japan Based on Nationwide Survey in 2009. Int J Rheumatol. 2012; 2012:358-371.","journal-title":"Int J Rheumatol"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Hisanori Umehara and others, The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD, Modern Rheumatology 2021: 3; 529-533.","DOI":"10.1080\/14397595.2020.1859710"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1136\/annrheumdis-2019-216561","article-title":"The 2019 American College of Rheumatology\/European League Against Rheumatism classification criteria for IgG4-related disease","volume":"79","author":"Wallace","year":"2020","unstructured":"3. Wallace ZS, Naden RP, Chari S Members of the ACR\/EULAR IgG4-RD Classification Criteria Working Group, et al. The 2019 American College of Rheumatology\/European League Against Rheumatism classification criteria for IgG4-related disease. Annals of the Rheumatic Diseases 2020;79:77-87.","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"9","key":"ref3","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1080\/1744666X.2017.1354698","article-title":"Diagnostic and treatment workup for IgG4-related disease","volume":"13","author":"Abraham","year":"2017","unstructured":"4. Abraham M, Khosroshahi A. Diagnostic and treatment workup for IgG4-related disease. Expert Rev Clin Immunol. 2017;13(9):867-875.","journal-title":"Expert Rev Clin Immunol"},{"issue":"11","key":"ref4","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1136\/gutjnl-2012-302886","article-title":"Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience","volume":"62","author":"Hart","year":"2013","unstructured":"5. Hart PA, Topazian MD, Witzig TE, Clain JE, Gleeson FC, Klebig RR, et al. Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Gut. 2013; 62(11):1607-15.","journal-title":"Gut"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1007\/s00535-003-1175-y","article-title":"Kamisawa T Funata N Hayashi Y Eishi Y Koike M A new clinicopathological entity of IgG4-related autoimmune disease","volume":"38","author":"6","year":"2003","unstructured":"6. Kamisawa T Funata N Hayashi Y Eishi Y Koike M A new clinicopathological entity of IgG4-related autoimmune disease. Journal of Gastroenterology . 2003;38:982-984.","journal-title":"Journal of Gastroenterology"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1002\/art.39205","article-title":"Wallace ZS Deshpande V Mattoo H Mahajan VS Kulikova M -related disease: clinical and laboratory features in one hundred twenty-five patients","volume":"67","author":"7","year":"2015","unstructured":"7. Wallace ZS Deshpande V Mattoo H Mahajan VS Kulikova M -related disease: clinical and laboratory features in one hundred twenty-five patients. Arthritis Rheumatology. 2015;67:2466-2475.","journal-title":"Arthritis Rheumatology"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Karadeniz H, Vaglio A. IgG4-related disease: a contemporary review. Turk J Med Sci. 2020 Nov 3;50(SI-2):1616-1631.","DOI":"10.3906\/sag-2006-375"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3109\/03009742.2015.1055796","article-title":"IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients","volume":"45","author":"Campochiaro","year":"2016","unstructured":"9. Campochiaro C, Ramirez GA, Bozzolo EP, Lanzillotta M, Berti A et al. IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients. Scandi Journal of Rheumatology 2016; 45: 135-145.","journal-title":"Scandi Journal of Rheumatology"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/S0025-6196(11)61189-0","article-title":"Treatment of benign orbital pseudolymphomas with the monoclonal anti-CD20 antibody rituximab","volume":"82","author":"Witzig","year":"2007","unstructured":"10. Witzig TE, Inwards DJ, Habermann TM, Dogan A, Kurtin PJ et al. Treatment of benign orbital pseudolymphomas with the monoclonal anti-CD20 antibody rituximab. Mayo Clinic Proceedings 2007; 82: 692-699.","journal-title":"Mayo Clinic Proceedings"}],"container-title":["ARP Rheumatology"],"original-title":[],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T06:59:47Z","timestamp":1715497187000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.arprheumatology.com\/section.php?id=1684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":10,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,3]]}},"URL":"https:\/\/doi.org\/10.63032\/duxg5519","relation":{},"ISSN":["2795-4552"],"issn-type":[{"type":"electronic","value":"2795-4552"}],"subject":[],"published":{"date-parts":[[2024,3]]}}}